Unlocking strategic value: Data as a key asset in SBDD

by Dr. Neil Taylor

Structure-Based Drug Design (SBDD) has evolved significantly over the decades, transitioning from a largel...

READ MORE

How advances in machine learning and AI are shaping the future of drug development by solving the scoring challenge.

by Dr. Neil Taylor AI in drug discovery has revolutionised th...

READ MORE